BBX Logo Beta

华检医疗 (1931)

Crypto Stocks
华检医疗
Tue, 5/12/2026, 08:49:51 AM
logo
华检医疗
HKEX · $1931
Non-Strategic Token Holding
$0.89
+1.14%
Company Information

Positioned as a globally leading Web3 trading platform based on high-tech assets in medical innovative drugs ("NewCo"). Through mergers and acquisitions ✖ NewCo dual-drive, the acquired globally potential value NewCo assets will be deeply integrated with Web3 technology, transforming them into globally liquid RWA, and issuing a proprietary stablecoin (IVDDollar) ("IVDD") as a universal medium for transactions within the ecosystem, used for paying transaction fees, asset purchases, and cross-border financing, forming a closed-loop system of "exchange + stablecoin" to address the long-standing pain points in the innovative drug industry, such as low financing efficiency, poor asset liquidity, and high globalization thresholds.

Coin Reserve Status
ETH
币种储备情况
Main Held Cryptocurrency: Ethereum
Amount Held: No data available (invested HKD 880 million for purchase)
Current Value: No data available
Proportion of Total Assets: No data available
Reserve Management Strategy: Huajian Medical invested HKD 880 million to purchase Ethereum as reserves and plans to apply for a US stablecoin license. This indicates that its reserve management strategy includes incorporating cryptocurrency as part of asset allocation and may further engage in the cryptocurrency market by issuing stablecoins.
Long press to scan QR code for more content
华检医疗

华检医疗

$1931HKEX
Non-Strategic Token Holding
Buy Token

Company Information

Positioned as a globally leading Web3 trading platform based on high-tech assets in medical innovative drugs ("NewCo"). Through mergers and acquisitions ✖ NewCo dual-drive, the acquired globally potential value NewCo assets will be deeply integrated with Web3 technology, transforming them into globally liquid RWA, and issuing a proprietary stablecoin (IVDDollar) ("IVDD") as a universal medium for transactions within the ecosystem, used for paying transaction fees, asset purchases, and cross-border financing, forming a closed-loop system of "exchange + stablecoin" to address the long-standing pain points in the innovative drug industry, such as low financing efficiency, poor asset liquidity, and high globalization thresholds.
CEO
Mr. Xianya Lin
Founded
1993
Headquarters
Building 6, Room 602, Lane 299 Bisheng Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, China
EXCHANGE
HKEX
H
Annual High
$2.70
L
Annual Low
$0.88

Stock Chart

Business Model

Business Mode

  • Business Model: Huajian Medical's business model mainly includes the sales and manufacturing of medical equipment, as well as related after-sales services. In addition, the company actively expands into the blockchain and cryptocurrency fields, diversifying its business model by holding Ethereum and planning to issue stablecoins.

Profit Model

  • Profit Model: Huajian Medical's profit model comes from the sales, manufacturing, and after-sales service of medical equipment and consumables. At the same time, its investments in the cryptocurrency field (such as purchasing Ethereum) and the future issuance of stablecoins will also become new profit growth points. Its profitability is closely related to the demand in the medical market, product innovation, and the performance of the cryptocurrency market.

Profit Model Impact

  • The combination of Huajian Medical's profit model with cryptocurrency means that it not only generates revenue from traditional medical businesses but also explores new growth points through cryptocurrency investments and stablecoin issuance. For the cryptocurrency industry, this signifies that more traditional enterprises are beginning to recognize and invest in crypto assets, which helps to promote the mainstreaming and compliance of cryptocurrencies. Its plan to issue stablecoins may also bring more regulated and trustworthy digital assets to the cryptocurrency market, thereby facilitating the development of the digital economy.

Impact on Cryptocurrencies

  • Directly Affected Cryptocurrency: Ethereum
  • Impact Method and Mechanism: Huajian Medical purchases Ethereum as a reserve, directly increasing the demand for Ethereum and positively affecting its price. If a stablecoin is successfully issued in the future, it will further expand its influence in the cryptocurrency market.
  • Impact Degree Assessment: Moderate. Although the purchase amount is large, its direct impact is limited relative to Ethereum's overall market value. However, as a publicly listed company actively engaging in the cryptocurrency field, it may have a demonstration effect on market sentiment and encourage more traditional enterprises to enter the cryptocurrency space.
  • Indirectly Affected Cryptocurrencies: Other cryptocurrencies (such as Bitcoin and other tokens in the stablecoin ecosystem)